India to Venezuela: Lapatinib Export Trade Route

The India to Venezuela Lapatinib corridor is one of India's established pharmaceutical export routes, with 17 shipments documented worth a combined $65.5K USD. The route is dominated by MEDWISE OVERSEAS PRIVATE LIMITED , which alone accounts for roughly 38% of all export value, reflecting the consolidated nature of India's lapatinib manufacturing sector.

Across 5 active suppliers, the average shipment value stands at $3.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with lapatinib's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 15.6%, placing it at rank #2 among India's top lapatinib export destinations globally.

On the import side, key buyers of Indian lapatinib in Venezuela include TO, , TO, GLOBAL CARE PHARMA, C.A. and 3 others. TO, is the single largest importer with 2 shipments valued at $24.6K USD.

India's lapatinib exports to Venezuela are driven primarily by a handful of large-scale manufacturers. MEDWISE OVERSEAS PRIVATE LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Venezuela benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MEDWISE OVERSEAS PRIVATE LIMITED , MEDWISE OVERSEAS PRIVATE LIMITED, BETA DRUGS LIMITED — together account for 88% of total trade value on this route. The average shipment value of $3.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as lapatimed 250(lapatinib tabs 250mg)bn.bt and lapatimed-250 (lapatinib tablets 250 mg) , suggesting that buyers in Venezuela tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO, is the largest importer with 2 shipments worth $24.6K USD — representing 38% of all lapatinib imports from India on this route. A total of 6 buyers are active on this corridor.